Clarivate (CLVT) Competitors $4.84 +0.01 (+0.10%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$4.89 +0.04 (+0.91%) As of 02/21/2025 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CLVT vs. RTO, CART, FTAI, ALLE, ULS, MEDP, WPP, HQY, GLOB, and BILIShould you be buying Clarivate stock or one of its competitors? The main competitors of Clarivate include Rentokil Initial (RTO), Maplebear (CART), FTAI Aviation (FTAI), Allegion (ALLE), UL Solutions (ULS), Medpace (MEDP), WPP (WPP), HealthEquity (HQY), Globant (GLOB), and Bilibili (BILI). These companies are all part of the "business services" industry. Clarivate vs. Rentokil Initial Maplebear FTAI Aviation Allegion UL Solutions Medpace WPP HealthEquity Globant Bilibili Clarivate (NYSE:CLVT) and Rentokil Initial (NYSE:RTO) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends, earnings, community ranking and media sentiment. Does the MarketBeat Community believe in CLVT or RTO? Clarivate received 44 more outperform votes than Rentokil Initial when rated by MarketBeat users. Likewise, 53.33% of users gave Clarivate an outperform vote while only 30.77% of users gave Rentokil Initial an outperform vote. CompanyUnderperformOutperformClarivateOutperform Votes4853.33% Underperform Votes4246.67% Rentokil InitialOutperform Votes430.77% Underperform Votes969.23% Does the media favor CLVT or RTO? In the previous week, Clarivate had 20 more articles in the media than Rentokil Initial. MarketBeat recorded 23 mentions for Clarivate and 3 mentions for Rentokil Initial. Rentokil Initial's average media sentiment score of 1.31 beat Clarivate's score of 0.04 indicating that Rentokil Initial is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clarivate 1 Very Positive mention(s) 3 Positive mention(s) 13 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Neutral Rentokil Initial 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, CLVT or RTO? Clarivate has a beta of 1.17, meaning that its share price is 17% more volatile than the S&P 500. Comparatively, Rentokil Initial has a beta of 1.08, meaning that its share price is 8% more volatile than the S&P 500. Do institutionals and insiders believe in CLVT or RTO? 85.7% of Clarivate shares are held by institutional investors. Comparatively, 9.9% of Rentokil Initial shares are held by institutional investors. 22.8% of Clarivate shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts rate CLVT or RTO? Clarivate currently has a consensus price target of $7.10, indicating a potential upside of 46.54%. Given Clarivate's higher possible upside, analysts plainly believe Clarivate is more favorable than Rentokil Initial.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clarivate 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17Rentokil Initial 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 2.71 Is CLVT or RTO more profitable? Rentokil Initial has a net margin of 0.00% compared to Clarivate's net margin of -24.90%. Clarivate's return on equity of 9.07% beat Rentokil Initial's return on equity.Company Net Margins Return on Equity Return on Assets Clarivate-24.90% 9.07% 3.87% Rentokil Initial N/A N/A N/A Which has higher earnings & valuation, CLVT or RTO? Rentokil Initial has higher revenue and earnings than Clarivate. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClarivate$2.56B1.35-$911.20M-$0.96-5.05Rentokil Initial$6.68B1.91$473.93MN/AN/A SummaryClarivate beats Rentokil Initial on 10 of the 17 factors compared between the two stocks. Get Clarivate News Delivered to You Automatically Sign up to receive the latest news and ratings for CLVT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLVT vs. The Competition Export to ExcelMetricClarivateData processing & preparation IndustryComputer SectorNYSE ExchangeMarket Cap$3.44B$4.29B$26.22B$20.07BDividend YieldN/A2.63%2.74%3.65%P/E Ratio-5.0572.8346.3434.90Price / Sales1.3519.392,533.2815.64Price / Cash2.6134.8935.5720.85Price / Book0.706.576.864.92Net Income-$911.20M$38.21M$731.18M$1.02B7 Day Performance-1.22%-3.24%-2.05%-1.05%1 Month Performance-10.86%5.33%-0.12%-1.09%1 Year Performance-45.93%16.89%19.96%13.70% Clarivate Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLVTClarivate3.721 of 5 stars$4.85+0.1%$7.10+46.5%-45.3%$3.35B$2.56B-5.0512,000Analyst ForecastAnalyst RevisionNews CoverageRTORentokil Initial1.5783 of 5 stars$27.04+2.1%N/A-7.0%$13.65B$5.41B0.0062,900Positive NewsGap UpCARTMaplebear2.3815 of 5 stars$50.97+2.0%$48.96-3.9%+81.5%$13.09B$3.04B34.213,380FTAIFTAI Aviation3.9923 of 5 stars$113.59+5.3%$171.75+51.2%+142.3%$11.65B$1.17B-1,135.7940ALLEAllegion4.2564 of 5 stars$133.51+0.3%$140.83+5.5%-3.0%$11.61B$3.65B20.5112,400Earnings ReportAnalyst ForecastInsider TradeNews CoverageULSUL Solutions1.9548 of 5 stars$56.71-1.1%$49.00-13.6%N/A$11.35B$2.68B0.0015,233Earnings ReportAnalyst ForecastNews CoverageMEDPMedpace4.2681 of 5 stars$340.17-0.7%$381.44+12.1%-11.8%$10.57B$1.89B29.795,900WPPWPP0.8073 of 5 stars$48.31-1.1%N/A-3.4%$10.42B$18.46B0.00114,732Upcoming EarningsHQYHealthEquity2.0295 of 5 stars$112.69-1.1%$110.71-1.8%+35.6%$9.77B$999.59M103.393,150Positive NewsGLOBGlobant4.7518 of 5 stars$224.28-1.9%$230.28+2.7%-31.1%$9.66B$2.10B58.5629,150Earnings ReportAnalyst ForecastNews CoverageGap DownBILIBilibili1.4582 of 5 stars$21.99+10.9%$19.69-10.5%+121.3%$9.11B$3.19B-23.908,801Earnings ReportAnalyst ForecastOptions VolumeNews CoverageGap UpHigh Trading Volume Related Companies and Tools Related Companies RTO Alternatives CART Alternatives FTAI Alternatives ALLE Alternatives ULS Alternatives MEDP Alternatives WPP Alternatives HQY Alternatives GLOB Alternatives BILI Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:CLVT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clarivate Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Clarivate With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.